TICAM1 and esophageal squamous cell carcinoma: This suggests that poly(I:C)-induced signaling contributes to immune cell recruitment to ESCC cells via the TLR3/TICAM-1 pathway, though confirming activation of natural killer cells and recruitment of lymphocytes to the tumor microenvironment in ESCC will require further studies.